Skip to main content
SpringerLink
Log in

Actinic Keratosis

  • Chapter
European Handbook of Dermatological Treatments

Abstract

Solar keratosis. This term is more specific because “actinic” means that the keratosis is produced by rays of any kind, unlike “solar” that indicates specifically rays of the sun. In several countries, it is also known as senile keratosis, senile hyperkeratosis, keratoma senile and keratosis senilis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

5-FU:

5-fluorouracil

AK:

Actinic keratoses

ALA:

5-aminolevulinic acid

CIN or SIN:

Squamous intraepithelial neoplasia

CO2:

Carbon dioxide

CPG:

Computer pattern generator

DFS:

Diclofenac sodium

HD-OCT:

High-definition optical coherence tomography

IMG:

Ingenol mebutate gel

IMIQ:

Imiquimod

KIN:

Keratinocytic intraepithelial neoplasia

LED:

Light-emitting diodes

MAL:

Methyl ester 5-aminolevulinic acid

PDT:

Photodynamic therapy

PpIX:

Photosensitiser protoporphyrin IX

RTCs:

Randomised controlled trials

SCC:

Squamous-cell carcinoma

UVR:

Ultraviolet radiation

SORT:

Strength of recommendation taxonomy

SPF:

Sun protection factor

References

  • Ackerman AB. Respect at last for solar keratosis. Dermatopathol. 1997;3:101–3.

    Google Scholar 

  • Alsner S, González S, Ulrich M. Actinic keratosis. In: González S, editor. Reflectance confocal microscopy in dermatology: fundamentals and clinical applications. Madrid: Aula Médica Ed; 2012. p. 69–71.

    Google Scholar 

  • Askew DA, Mickan SM, Soyer P, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis – a systematic review of randomized controlled trials. Int J Dermatol. 2009;48:453–63.

    Article  CAS  Google Scholar 

  • Camacho FM. Remodelamiento cutáneo: perspectiva histórica. Piel. 2005a;20:504–17.

    Article  Google Scholar 

  • Camacho FM. Medium-depth and deep chemical peels. J Cosmet Dermatol. 2005b;4:117–28.

    Article  Google Scholar 

  • Carlson S, Bordeaux J. Treatment of actinic keratoses. In: Maibach HI, Gorouhi F, editors. Evidence based dermatology. 2nd ed. Shelton: People’s Medical Publishing House; 2011.

    Google Scholar 

  • Dirschka T, Bierhoff E, Pflugfelder A, Garbe C. Topical 3.0 % diclofenac in 2.5 % hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses. J Eur Acad Dermatol Venereol. 2010;24:258–63.

    Article  CAS  Google Scholar 

  • Gupta AK, Paquet M. Ingenol mebutate: a promising treatment for actinic keratoses and nonmelanoma skin cancers. J Cutan Med Surg. 2013;17:173–9.

    Article  CAS  Google Scholar 

  • Hanke CW, Moy RI, Roenigk RK, Roenigk Jr HH, et al. Current status of surgery in dermatology. J Am Acad Dermatol. 2013;69:972–1001.

    Article  Google Scholar 

  • Hirokawa D, Lee JB. Dermatoscopy: an overview of subsurface morphology. Clin Dermatol. 2011;29:557–65.

    Article  Google Scholar 

  • Krawtchenko N, Roewert-Huber J, Ulrich M, Mann I, Sterry W, Stockfleth E. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol. 2007;157 Suppl 2:34–40.

    Article  CAS  Google Scholar 

  • Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366(11):1010–9.

    Article  CAS  Google Scholar 

  • Lecha CM. Photoprotection and sunscreen. Monogr Dermatol. 2014;27(Supl.1):104–10.

    Google Scholar 

  • Martin G, Swanson N. Clinical findings using ingenol mebutate gel to treat actinic keratoses. J Am Acad Dermatol. 2013;68(Supp l):S39–48.

    Article  CAS  Google Scholar 

  • Schmitt AR, Bordeaux JS. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. Clin Dermatol. 2013;31:712–7.

    Article  Google Scholar 

  • Stockfleth E, Christophers E, Benninghoff B, Sterry W. Low incidence of new actinic keratoses after topical 5 % imiquimod cream treatment: a long-term follow-up study. Arch Dermatol. 2004;140:1542.

    Article  Google Scholar 

  • Stockfleth E, Kerl H, Zwingers T, Willers C. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Br J Dermatol. 2011;65:1101–8.

    Article  Google Scholar 

  • Stockfleth E, Zwingers T, Willers C. Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses. Eur J Dermatol. 2012;22:370–4.

    CAS  PubMed  Google Scholar 

  • Swanson N, Abramovits W, Berman B, Kulp J, Rigel DS, Levy S. Imiquimod 2.5 % and 3.75 % for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-weeks cycles. J Am Acad Dermatol. 2010;62:582–90.

    Article  CAS  Google Scholar 

  • Szeimies RM, Bichel J, Ortonne JP, Stockfleth E, Lee J, Meng TC. A phase II dose-ranging study of topical resiquimod to treat actinic keratosis. Br J Dermatol. 2008;159:205–10.

    Article  CAS  Google Scholar 

  • Weiss ET, Brauer JA, Anolik R, Reddy KK, et al. 1927-nm fractional resurfacing of facial actinic keratoses: a promising new therapeutic option. J Am Acad Dermatol. 2013;68:98–102.

    Article  Google Scholar 

  • Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169:502–18.

    Article  CAS  Google Scholar 

  • Werner RN, Stockfleth E, Connolly SM, Correia O, et al. International League of Dermatological Societies (ILDS) Evidence-based (S3) Guidelines for the reatment of Actinic Keratosis (ICD L57.0:D04). In cooperation with the European Dermatology Forum (EDF), 2015 (in press)

    Google Scholar 

  • Zalaudek I, Giacomel J, Schmid K, Bondino S, et al. Dermatoscopy of facial actinic keratoses, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. J Am Acad Dermatol. 2012;66:589–97.

    Article  Google Scholar 

Further Reading

  • Ballester-Sanchez R, Botella-Estrada R. Etiologic and epidemiologic factor of actinic keratoses. Monogr Dermatol. 2013;26 Suppl 1:11–3.

    Google Scholar 

  • Berman B, Cohen DE, Amini S. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents. Cutis. 2012;89:241–50.

    PubMed  Google Scholar 

  • Callen JP, Bickers DR, Moy RL. Actinic keratoses. J Am Acad Dermatol. 1997;36:650–3.

    Article  CAS  Google Scholar 

  • Camacho FM. Actinic keratosis. Introduction. Concept and classification. Monogr Dermatol. 2014;27 Suppl 1:3–5.

    Google Scholar 

  • Camacho FM, García-Hernández MJ. Modelado cutáneo (resurfacing). Concepto y fundamentos. In: Cisneros JL, Camacho FM, Trelles MA, editors. Láser en Dermatología y Dermocosmética. 2nd ed. Madrid: Grupo Aula Médica, S.L., Ed; 2008. p. 353–65.

    Google Scholar 

  • Cassarino DS, Barr RJ. SIN, not KIN. J Cutan Pathol. 2009;36:280.

    Article  Google Scholar 

  • de Berker D, McGregor JM, Hughes BR. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156:222–30.

    Article  Google Scholar 

  • Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT). Am Fam Physician. 2004;69:548–56.

    PubMed  Google Scholar 

  • España A. Actinic keratosis and field cancerization. Monogr Dermatol. 2013;26 Suppl 1:6–10.

    Google Scholar 

  • Falagas ME, Angelousi AG, Peppas G. Imiquimod for the treatment of actinic keratosis: a meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2006;55:537–8.

    Article  Google Scholar 

  • Fitzpatrick TB. The skin cancer cascade: from ozone depletion to melanoma. J Dermatol. 1996;28:816–20.

    Article  Google Scholar 

  • Garza Rodríguez V, Malvehy J. New diagnostic methods of the actinic keratoses. Monogr Dermatol. 2013;26 Suppl 1:40–50.

    Google Scholar 

  • Gilaberte Y, Pérez Lorenz JB, Juarranz A. Photodynamic therapy in the diagnosis and treatment of actinic keratoses. Monogr Dermatol. 2013;26 Suppl 1:51–8.

    Google Scholar 

  • Gras J. Ingenol mebutate: a new option for actinic keratosis treatment. Drugs Today (Barc). 2013;49:15–22.

    Article  CAS  Google Scholar 

  • Hadley G, Derry S, Moore RA. Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol. 2006;126:1251–5.

    Article  CAS  Google Scholar 

  • Hepplewhite A. Management of patients with actinic keratoses. Br J Nurs. 2012;21(Suppl):S27–30.

    Article  Google Scholar 

  • Jansen R, Wang SQ, Burnett M, Osterwalder U, Lim HW. Photoprotection. Part I. Photoprotection by naturally occurring, physical, and systemic agents. J Am Acad Dermatol. 2013;69:853–64.

    Article  Google Scholar 

  • Jansen R, Wang SQ, Burnett M, Osterwalder U, Lim HW. Photoprotection. Part II. Sunscreen: development, efficacy, and controversial. J Am Acad Dermatol. 2013;69:867–80.

    Article  Google Scholar 

  • Jorizzo J, Dinehart S, Matheson R, Moore JK, et al. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol. 2007;57:265–8.

    Article  Google Scholar 

  • Maier T, Braun-Falco M, Laubender RP, Ruzicka T, Berking C. Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. Br J Dermatol. 2013;168:120–8.

    Article  CAS  Google Scholar 

  • Melkonian S, Argos M, Pierce BL, Chen Y, Islam T, Ahmed A, et al. A prospective study of the synergistic effects of arsenic exposure and smoking, sun exposure, fertilizer use, and pesticide use on risk of premalignant skin lesions in Bangladeshi men. Am J Epidemiol. 2011;173:183–91.

    Article  Google Scholar 

  • Ondo AL, Padilla S, Miedler JD, Cockerell CJ, et al. Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study. Dermatol Surg. 2012;38:1469–76.

    Article  CAS  Google Scholar 

  • Poziomcyk CS, Dornelles MA, Köche B, Dornelles SI. Pain evaluation in the cryosurgery of actinic keratoses. An Bras Dermatol. 2011;86:645–50.

    Article  Google Scholar 

  • Rios Martín JJ. Histopathology of actinic keratoses. Histopathological forms. Monogr Dermatol. 2013;26 Suppl 1:26–30.

    Google Scholar 

  • Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol. 2012;66:486–93.

    Article  CAS  Google Scholar 

  • Sander CA, Pfeiffer C, Kligman AM, Plewig G. Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol. 1997;36:236–8.

    Article  CAS  Google Scholar 

  • Slaughter DP, Southwick HW, Smejkal W. Field cancerization on oral stratified squamous epithelium. Cancer (Phila). 1953;6:963–8.

    Article  CAS  Google Scholar 

  • Xu D, Yuan R, Gu H, et al. The effect of ultraviolet radiation on the transforming growth factor beta 1/Smads pathway and p53 in actinic keratosis and normal skin. Arch Dermatol Res. 2013;305:777–86.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical-Surgical Dermatology Department, Hospital Universitario Virgen Macarena, School of Medicine, University of Seville, Seville, Spain

    Francisco M. Camacho-Martinez (Full Professor of Dermatology)

Authors
  1. Francisco M. Camacho-Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francisco M. Camacho-Martinez .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Andreas Syggros Hospital University of Athens, Athens, Greece

    Andreas D. Katsambas  & Clio Dessinioti  & 

  2. University of Rome “G. Marconi”, Rome, Italy

    Torello M. Lotti

  3. Centro Studi per la Ricerca Multidisciplinare Rigenerativa (CSRMR), Rome, Italy

    Torello M. Lotti

  4. Unit of Dermatology, University of Pisa, Pisa, Italy

    Angelo Massimiliano D’Erme

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Camacho-Martinez, F.M. (2015). Actinic Keratosis. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45139-7_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45138-0

  • Online ISBN: 978-3-662-45139-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation